IDW Pharma
ActiveSummary
IDW Pharma has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €46,772 and a net result of €41,772. Its solvency ranks better than 71% of 9,585 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
2026
18-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 18 days late
2025
13-08
Gazette deed
Registered officeRegistered-office move · Director in office3 facts ▸
Gazette deed
Registered office
Registered-office move · Director in office3 facts ▸
- General meeting, 20-06-2025
- Registered-office move, Wouters Lefebvreplein 35A 2830 Blaasveld
- Director in office, Ine De Wit (director)
13-02
Gazette deed
IncorporationAppointment: DE WIT Ine (director) · Founder · Founding capital10 facts ▸
Gazette deed
Incorporation
Appointment: DE WIT Ine (director) · Founder · Founding capital10 facts ▸
- Incorporation, 11-02-2025
- Founder, DE WIT Ine
- Founding capital, €5,000
- Bank account, “bijzondere rekening, vennootschap in oprichting” (deed in Dutch)
- Registered office clause, “2830 Willebroek,Fabrieksstraat 19/0102” (deed in Dutch)
- Director appointment, DE WIT Ine (director (not named in the articles))
- Other provision, “geen beschikkingsbeperking, niet getroffen door beschikkingsbeperking die verhindert mandaat op te nemen” (deed in Dutch)
- Pre-incorporation commitments, “takeover, alle verbintenissen,verplichtingen en activiteiten in naam en voor rekening van vennootschap in oprichting” (deed in Dutch)
- Power of attorney, BV Van den Bempt – Michel & Partners
- Other provision, “toereikende,accurate en actuele informatie over uiteindelijke begunstigde(n), UBO-register” (deed in Dutch)
Gazette deedNBB filing
2 of 2 deeds read